ArticleScience progress
Exploratory analysis of BNP, NLR and APACHE II in assessing the mortality risk of elderly patients with severe pneumonia.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aimsSevere pneumonia represents a serious threat to the health of elderly individuals. This study aims to exploratory analyse the effect of B-type natriuretic peptide (BNP), the neutrophil to lymphocyte ratio (NLR), and APACHE II scores for assessing the 28-day mortality risk in elderly patients with severe pneumonia.MethodsOur study enrolled 80 elderly patients with severe pneumonia (53 males and 27 females). The associations of NLR, oxygenation index (PaO2/FiO2), and acute physiology and chronic health score II (APACHE II) with 28-day mortality risk were assessed using multivariable logistic regression hazards model. The predictive value of BNP, NLR, and APACHE II scores for 28-day mortality risk in this patient population was assessed by receiver operating characteristic (ROC) curves.ResultsBNP (odds ratio [OR], 1.007; 95% confidence interval [CI], 1.002-1.012;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.